In the pharmaceutical sector, nothing happens in a vacuum. The rising demand for statins - cholesterol-lowering drugs, is driven by an increasing number of people diagnosed with cardiovascular illnesses worldwide. Modern sedentary lifestyles, high cholesterol diets and aging population contribute to the growing prevalence of these diseases. As a result,...
Discover more insightsThe global pharmaceutical market is witnessing significant growth in the segment of erythropoietin drugs. Factors such as a rapidly aging population, advances in bio-similar manufacturing technology and increasing prevalence of conditions like chronic kidney disease and cancer, which lead to anemia, have driven demand for these drugs. The highly competitive...
Discover more insightsThe erythropoietin market is witnessing substantial growth due to increased global incidence of renal diseases and cancer, conditions which catalyze the demand for erythropoietin. The drug, essential in the production of red blood cells, is key to kidney dialysis and chemotherapy procedures. Additionally, the market's expansion is fuelled by the...
Discover more insightsTumor necrosis factor (TNF) inhibitors have revolutionized the treatment of autoimmune diseases globally. They have become particularly critical in the management of conditions such as rheumatoid arthritis, Crohn's disease, and psoriasis. These pharmaceutical innovations have significantly improved patient outcomes and quality of life. Additionally, TNF inhibitors are increasingly being recognized...
Discover more insights